FDA-approved drug may slow beta cell destruction in type 1 diabetes patients

DALLAS -- Dec. 4, 2009 -- New findings by UT Southwestern researchers suggest that a drug already used to treat autoimmune disorders might also help slow the destruction of insulin-producing cells in patients recently diagnosed with insulin-dependent (type 1) diabetes.

Read the whole article on Science Blog

More from Science Blog